ACAmit Chaudhary

Amit Chaudhary

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Amit Chaudhary has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Biofilm-responsive nanogels: a closed-loop system for on-demand antimicrobial release for chronic wounds

    by Shreya Kaul, Aruna Sharma, Neha Jain, Sweta Bawari, Amit Chaudhary, Upendra Nagaich

  • Nanogel-Enabled Transdermal Platforms for Targeted Management of Biofilm-Associated Chronic Infections

    by Aruna Sharma, Ameya Sharma, Divya Dheer, Amit Chaudhary, Neha Jain

    Introduction/Objective: The problem of biofilm infections is of considerable clinical importance because of the presence of an EPS matrix, metabolic heterogeneity, and antimicrobial tolerance, leading to low penetration of antibiotics and contributing to the failure of therapy and the development of antimicrobial resistance. This review attempts to emphasize the advantages of using nanogel-based transdermal drug delivery for the efficient treatment of biofilm-associated infections. Methods: The review of the relevant literature has been conducted in order to assess the potential of nanogel-based delivery systems, especially as transdermal approaches in the therapy of biofilmassociated infections. Results: Nanogels have unique properties: they are nano-sized, contain high amounts of water, and are polymeric, allowing them to penetrate into biofilms. They can load hydrophilic and lipophilic compounds and allow the co-delivery of antibiotics with agents that disrupt biofilms, such as enzymes and quorum-sensing inhibitors. In transdermal formulations, nanogels can offer controlled drug release, improved penetration and retention in the tissues, and lower systemic exposure. The preclinical results show enhanced biofilm disruption, low minimum biofilm eradication concentration, and faster wound healing. Discussion: Some of the recent developments are hybrid systems that combine nanogels with microneedles or hydrogel patches that can ensure site-specific and controlled drug delivery. Patent developments such as WO2023212124A1, EP4514412A1, and US 11,129,975 further support this fact and reflect the translational potential of these systems. Nonetheless, scalability and stability have emerged as major obstacles to clinical translation. Conclusion: Nanogel-mediated transdermal delivery is one of the most exciting approaches that could be used for treating biofilm infections. Though faced with some issues such as scalability, stability, sterilization, and standardization, development of smart materials and drug delivery systems and personalized medicine could help in translating this approach into clinical use.

  • Bioconjugates for breast cancer theranostics: improving target selectivity and treatment efficacy

    by Neha Jain, Shreya Kaul, Rupali Verma, Aruna Sharma, Manisha Pandey, Amit Chaudhary, Upendra Nagaich

    1. Breast cancer is one of the most frequently diagnosed cancers worldwide, and it is a markedly heterogeneous disorder. Heterogeneity in breast cancer is seen at various levels, such as interpatie...

  • Open Access

    Exploration of Skin Permeability Possibility of Cubogels for Keratosis-like Skin Conditions

    by Shailja Shailja, Neha Jain, Amit Chaudhary, Upendra Nagaich, Shailja

    Actinic keratosis (AK) is a chronic skin condition caused primarily by prolonged sun exposure, leading to the development of uneven, scaly patches on sun-exposed areas like the face, chest, and neck. Traditional treatments often encounter challenges such as poor skin permeability and formulation stability. This study investigates the potential of cubosomal hydrogels for enhancing the treatment of AK, focusing on their permeability, and effectiveness. Cubosomes, a type of liquid crystalline nanoparticle, are known for their controlled release and improved skin penetration capabilities. We formulated tretinoin-loaded cubosomes and incorporated them into carbopol-based hydrogels, referred to as cubogels, to address issues related to stability and ease of application. The formulation of tretinoin-loaded cubosomes was optimized, resulting in particles with a size of 69.5 nm, a polydispersity index of 0.312, and an entrapment efficiency of 82.13%. These cubosomes were then dispersed in hydrogels made with varying concentrations of Carbopol 940 (0.5%, 1.0%, and 1.5%). The cubogels were evaluated for physical properties, including appearance, pH, viscosity, spreadability, and drug content uniformity. The hydrogels exhibited good homogeneity and appropriate pH levels, with CG2 (1.0% Carbopol) showing the best spreadability and drug content uniformity. Ex-vivo studies using goat ear pinna demonstrated that CG2 provided the highest steady-state flux and permeability coefficient, indicating superior skin penetration. The cumulative drug permeation over 24 hours was also higher for CG2 compared to the other formulations. In conclusion, the incorporation of cubosomes into hydrogels significantly enhances the stability and skin permeability of tretinoin, offering a promising approach for the treatment of actinic keratosis. Future studies should focus on clinical evaluation to confirm these findings and further optimize the formulation for broader therapeutic applications.


  • Open Access

    RP HPLC Method Development for Simultaneous Estimation of Etoricoxib and Thiocolchicoside

    by Anchal Sharma, Amit Chaudhary, Bhupendra Singh

    A simple, specific and accurate reverse phase high performance liquid chromatography (RP-HPLC) method was developed and validated for simultaneous estimation of Etoricoxib and Thiocolchicoside in bulk and solid dosage form. Separation was achieved by Zorbax C-18 analytical column having dimension (250mm * 4.6 mm i.d 5.0 µm) using methanol and water (60:40) as mobile phase and flow rate was 0.7ml/min. The detection was carried out at 283 nm wavelength using UV detector. The total chromatographic sample time per analysis was about 14.0 minutes with thiocolchicoside eluted at retention time 3.523 min and etoricoxib eluted at retention time 9.627 min. The method was validated for accuracy, precision, specificity, rapid, reliable and reproducible. LOD and LOQ value for etoricoxib and thiocolchicoside were found to be 0.332, 0.996 ppm and 0976, 0.928 ppm respectively. Regression Equation for Etoricoxib was y = 0.006x + 0.149 and regression equation for thiocolchicoside was Y = 0.030x + 0.086. As the run time was increased the retention time was decreased, so the method is simple and economical and can be adopted by regular quality control in industries and also in research laboratories.